Pubblicazioni

Similar levels of efficacy of two different maintenance doses of adalimumab on clinical severity and quality of life of patients with hidradenitis suppurativa

2022 - JOURNAL OF CLINICAL MEDICINE

Fania, L; Giovanardi, G; Samela, T; Caposiena, D; Chiricozzi, A; Antonelli, F; Saraceni, P; Elia, F; Garcovich, S; Ciccone, D; Cannizzaro, Mv; Miraglia, E; Iacovino, C; Giustini, S; Skroza, N; Mambrin, A; Potenza, C; Bianchi, L; Peris, K; Abeni, D.

The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa. Results of a prospective European cohort study

2021 - JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

van Straalen, K. R.; Tzellos, T.; Guillem, P.; Benhadou, F.; Cuenca-Barrales, C.; Daxhelet, M.; Daoud, M.; Efthymiou, O.; Giamarellos-Bourboulis, E. J.; Jemec, G. B. E.; Katoulis, A. C.; Koenig, A.; Lazaridou, E.; Marzano, A. V.; Matusiak, L.; Molina-Leyva, A.; Moltrasio, C.; Pinter, A.; Potenza, C.; Romani, J.; Saunte, D. M.; Skroza, N.; Stergianou, D.; Szepietowski, J.; Trigoni, A.; Vilarrasa, E.; van der Zee, H. H.